3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with Diabetes, Gestational in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Jin, H; Yi, J; Yu, X; Zhang, R; Zhang, S; Zhang, X | 1 |
| Connelly, PW; Hanley, AJ; Kramer, CK; Retnakaran, R; Sermer, M; Ye, C; Zinman, B | 1 |
2 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Diabetes, Gestational
| Article | Year |
|---|---|
Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women.
Topics: Adult; Biomarkers; Cohort Studies; Diabetes, Gestational; Female; Follow-Up Studies; Furans; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Insulin-Secreting Cells; Pregnancy; Prognosis; Propionates | 2018 |
Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes.
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Furans; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Placental Lactogen; Postpartum Period; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Prolactin; Propionates; Prospective Studies; Regression Analysis; Risk Factors | 2016 |